Published in Brain Res on February 23, 2011
Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J Neuroinflammation (2012) 0.89
Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling. Brain Behav Immun (2014) 0.81
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 15.15
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med (2005) 2.51
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci (2003) 2.37
TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine (Phila Pa 1976) (2004) 1.93
Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol (2005) 1.51
Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development (1990) 1.47
Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res (1998) 1.40
Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci (2006) 1.37
Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett (1987) 1.34
Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci (2003) 1.32
The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J (2008) 1.29
Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience (1989) 1.26
Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain (2007) 1.21
Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol (2004) 1.20
The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One (2009) 1.18
Satellite cells surrounding axotomised rat dorsal root ganglion cells increase expression of a GFAP-like protein. Neurosci Lett (1989) 1.15
Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain (2010) 1.11
Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res (1987) 1.09
Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci (2002) 1.08
Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain (2006) 0.99
Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J Neurochem (2008) 0.99
Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc Natl Acad Sci U S A (1997) 0.97
Galanin-like immunoreactivity in capsaicin sensitive sensory neurons and ganglia. Brain Res Bull (1985) 0.97
Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat. Neurosci Res (2007) 0.97
Up-regulation of TNFalpha in DRG satellite cells following lumbar facet joint injury in rats. Eur Spine J (2006) 0.94
Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo. Brain Res (1991) 0.93
Partial and complete sciatic nerve injuries induce similar increases of neuropeptide Y and vasoactive intestinal peptide immunoreactivities in primary sensory neurons and their central projections. Neuroscience (1998) 0.90
Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy. Exp Brain Res (1996) 0.90
Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp Neurol (2010) 0.89
Differential expression of galanin immunoreactivities in the primary sensory neurons following partial and complete sciatic nerve injuries. Neuroscience (1997) 0.89
Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice. Neuroreport (2007) 0.89
Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc Natl Acad Sci U S A (1998) 0.86
Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain (1994) 0.86
Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin. Eur J Pharmacol (2001) 0.85
Interactions of galanin and morphine in the spinal antinociception in rats with mononeuropathy. Brain Res (2000) 0.85
gp130 cytokines, leukemia inhibitory factor and interleukin-6, induce neuropeptide expression in intact adult rat sensory neurons in vivo: time-course, specificity and comparison with sciatic nerve axotomy. Neuroscience (1998) 0.82
Generation and phenotypic characterization of a galanin overexpressing mouse. Neuroscience (2005) 0.82
An interaction of opioids and galanin in dorsal horn of the spinal cord in mononeuropathic rats. Regul Pept (2000) 0.81
Galanin expression in neuropathic pain: friend or foe? Ann N Y Acad Sci (1998) 0.79
Decrease in spinal CGRP and substance P is not related to neuropathic pain in a rat model. Neuroreport (2001) 0.78
Changes in calcitonin gene-related peptide immunoreactivity in the rat dorsal horn following electrical stimulation of the sciatic nerve. Neurosci Lett (1990) 0.76
Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2014) 2.97
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med (2005) 2.51
Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur J Neurosci (2009) 2.03
Forearm compartment syndrome from intravenous mannitol extravasation during general anesthesia. Anesth Analg (2003) 1.76
Capnography accurately detects apnea during monitored anesthesia care. Anesth Analg (2004) 1.67
Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol (2009) 1.59
Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia (2003) 1.54
Effects of heart rate changes on arterial distensibility in humans. Hypertension (2003) 1.52
Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg (2011) 1.51
Selective-site pacing in paediatric patients: a new application of the Select Secure system. Europace (2009) 1.49
NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. J Biol Chem (2005) 1.47
IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. Brain (2011) 1.37
A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther (2010) 1.33
EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta (2008) 1.31
Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat. Restor Neurol Neurosci (2007) 1.30
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain (2011) 1.25
Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res (2003) 1.21
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res (2012) 1.20
Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology (2009) 1.16
A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol (2002) 1.16
EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury. Stem Cells (2010) 1.15
Acute pain management for patients undergoing thoracotomy. Ann Thorac Surg (2003) 1.14
Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem (2009) 1.13
Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain (2010) 1.11
The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg (2008) 1.10
Astroglial nuclear factor-kappaB regulates learning and memory and synaptic plasticity in female mice. J Neurochem (2007) 1.08
Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression. Brain Res (2007) 1.02
A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma. Am J Hum Genet (2002) 1.00
Nuclear factor kappa B signaling initiates early differentiation of neural stem cells. Stem Cells (2012) 0.99
Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma (2002) 0.99
Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci (2004) 0.99
Multicenter assessment of the Iowa Satisfaction with Anesthesia Scale, an instrument that measures patient satisfaction with monitored anesthesia care. Anesth Analg (2011) 0.96
EphrinBs regulate D-serine synthesis and release in astrocytes. J Neurosci (2010) 0.96
Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP). J Neurochem (2002) 0.96
TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation. J Biol Chem (2004) 0.95
Clinical experience with a single catheter for mapping and ablation of pulmonary vein ostium. J Cardiovasc Electrophysiol (2008) 0.95
Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol (2003) 0.94
Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J Neurotrauma (2010) 0.92
A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Novartis Found Symp (2002) 0.92
An isoform of GTPase regulator DOCK4 localizes to the stereocilia in the inner ear and binds to harmonin (USH1C). J Mol Biol (2006) 0.92
Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol (2004) 0.92
Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides. Drug Dev Res (1998) 0.91
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol. Ther Clin Risk Manag (2009) 0.91
Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. Europace (2006) 0.90
Neural progenitors proliferation is inhibited by EphB3 in the developing subventricular zone. Int J Dev Neurosci (2010) 0.90
Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury. Exp Neurol (2006) 0.90
Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats. Eur J Pharmacol (2003) 0.90
The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med (2012) 0.90
Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice. Neuroreport (2007) 0.89
Nuclear factor-κB activation in Schwann cells regulates regeneration and remyelination. Glia (2012) 0.89
Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J Neuroinflammation (2012) 0.89
Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain. Neuropharmacology (2008) 0.89
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology (2009) 0.88
Inhibition of astroglial NF-κB enhances oligodendrogenesis following spinal cord injury. J Neuroinflammation (2013) 0.87
Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. Neurobiol Dis (2013) 0.87
CYP2D6 poor metabolizer genotype and smoking predict severe postoperative pain in female patients on arrival to the recovery room. Pain Med (2012) 0.87
Combination Drug Therapy for Pain following Chronic Spinal Cord Injury. Pain Res Treat (2012) 0.87
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure. Hypertension (2004) 0.87
Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol (2005) 0.87
Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Anesthesiology (2013) 0.87
Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain. Pharmacol Biochem Behav (2010) 0.87
Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma. PLoS One (2013) 0.86
Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation. Exp Neurol (2011) 0.85
TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord. Cell Transplant (2002) 0.85
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. Brain Res (2011) 0.84
Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise. J Neuroimmunol (2013) 0.84
IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages. J Immunol (2013) 0.84
Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways. J Cyst Fibros (2010) 0.83
Neuronal glutamate transporter EAAT4 is expressed in astrocytes. Glia (2003) 0.83
Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anaesth (2009) 0.83
NMDA antagonist peptide supplementation enhances pain alleviation by adrenal medullary transplants. Cell Transplant (2005) 0.83
Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope (2003) 0.82
Enhancement of morphine antinociception with the peptide N-methyl-D-aspartate receptor antagonist [Ser1]-histogranin in the rat formalin test. Brain Res (2006) 0.82
Pain and genetics. Curr Opin Anaesthesiol (2012) 0.82
Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. J Pharmacol Exp Ther (2005) 0.82
The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain. J Neurotrauma (2011) 0.82
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse. ASN Neuro (2013) 0.81
Murine neonates infected with Yersinia enterocolitica develop rapid and robust proinflammatory responses in intestinal lymphoid tissues. Infect Immun (2013) 0.81
An Intensive Locomotor Training Paradigm Improves Neuropathic Pain following Spinal Cord Compression Injury in Rats. J Neurotrauma (2015) 0.80
Chronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression. J Neuroinflammation (2014) 0.80
CYP3A4 * 1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients. Pharmacology (2015) 0.80
Polymorphism in the interleukin-1 receptor antagonist gene is associated with serum interleukin-1 receptor antagonist concentrations and postoperative opioid consumption. Anesthesiology (2011) 0.80
Prolonged nociceptive responses to hind paw formalin injection in rats with a spinal cord injury. Neurosci Lett (2008) 0.80
Inhibition by the chromaffin cell-derived peptide serine-histogranin in the rat's dorsal horn. Neurosci Lett (2007) 0.80
Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain. J Rehabil Res Dev (2009) 0.80
Enhanced viability and neuronal differentiation of neural progenitors by chromaffin cell co-culture. Brain Res Dev Brain Res (2002) 0.80